← Back to Patent Explorer
US4387160A Expired / Lapsed US ⏱️ 0.0 years remaining

Immunochemical assay for creatine kinase-MB isoenzyme

Assignee: Roche Diabetes Care Inc
•
Filing: 1981-02-17
•
Granted: 1983-06-07
•
Expires: 2001-02-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An immunochemical process and test kit for determining accurately the amount of creatine kinase-MB isoenzyme (CK-MB) in biological fluids employing two separate immunoassays to a single sample of the biological fluid. This process and test kit are useful in diagnosing myocardial infarct.

Inventors

  • 👤 Magdalena U. Gomez
  • 👤 Marvin L. Miller
  • 👤 Richard W. Wicks

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 10:57
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/573; Y; Y10; Y10S; Y10S435/00; Y10S435/971

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 241 words
A process for quantitatively determining in a biological fluid sample the presence of creatine kinase-MB isoenzyme where the creatine kinase can occur in biological fluids in a plurality of isoenzyme forms containing the subunit M or B or both, the process comprising: a. incubating in a first reaction vessel a first of two portions of the biological fluid sample with a first antibody which selectively binds immunologically with the creatine kinase isoenzymes containing the M subunit by selective immunoinhibition of the M subunit in the first portion of the sample and thereafter quantitatively measuring the B isoenzyme activity of the first portion of the sample, b. incubating in a separate reaction vessel the second of two portions of the biological fluid sample with: (i) an antibody which selectively binds immunologically with the creatine kinase isoenzymes containing the M subunit in the second portion sample; and (ii) a second antibody which selectively binds immunologically to form a solid phase with the antibody binding the creatine kinase isoenzymes containing the M subunit, to produce as a precipitate the reaction product of said second antibody with said other antibody and said creatine kinase isoenzymes containing the M subunit and thereafter quantitatively measuring the B isoenzyme activity of the supernatant in said second portion; and c. determining the CK-MB activity in said sample from said measurements through the substraction of the measurement obtained in the second portion, from the measurement obtained in the first portion.
Claim 2
Dependent Claim 241 words
A process for quantitatively determining in a biological fluid sample the presence of creatine kinase-MB isoenzyme where the creatine kinase can occur in biological fluids in a plurality of isoenzyme forms containing the subunit M or B or both, the process comprising: a. incubating in a first reaction vessel a first of two portions of the biological fluid sample with a first antibody which selectively binds immunologically with the creatine kinase isoenzymes containing the M subunit by selective immunoinhibition of the M subunit in the first portion of the sample and thereafter quantitatively measuring the B isoenzyme activity of the first portion of the sample, b. incubating in a separate reaction vessel the second of two portions of the biological fluid sample with: (i) an antibody which selectively binds immunologically with the creatine kinase isoenzymes containing the M subunit in the second portion sample; and (ii) a second antibody which selectively binds immunologically to form a solid phase with the antibody binding the creatine kinase isoenzymes containing the M subunit, to produce as a precipitate the reaction product of said second antibody with said other antibody and said creatine kinase isoenzymes containing the M subunit and thereafter quantitatively measuring the B isoenzyme activity of the supernatant in said second portion; and c. determining the CK-MB activity in said sample from said measurements through the substraction of the measurement obtained in the second portion, from the measurement obtained in the first portion.
Claim 3
Dependent Claim 14 words
A process according to claim 1 wherein the biological fluid sample is blood serum.
Claim 4
Dependent Claim 43 words
A process according to claim 1 wherein the first antibody of step (a) and the antibody binding the creatine kinase isoenzyme containing the M subunit of step (b) are goat anti-creatine kinase-MM, and the second antibody of step (b) is donkey anti-goat IgG.
Claim 5
Dependent Claim 16 words
A process according to claim 1 wherein the second antibody is bound to a solid support.
Claim 6
Dependent Claim 12 words
A process according to claim 4 wherein the solid support is polyvinylidenefluoride.
Claim 7
Dependent Claim 19 words
A process according to claim 1 wherein the enzymatic activity of B isoenzyme is determined by a spectrophotometric assay.
Claim 8
Dependent Claim 17 words
A process according to claim 6 wherein the spectrophotometric assay comprises: an enzyme-co enzyme and substrate mixture.

References Cited (Backward Citations)

US3932221A Cited
US4012285A Cited
US3843443A Cited
US4067775A Cited
US4224406A Cited
US4298592A Cited
US4353982A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-06-06 1986-12-06 1987-06-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-06-06 1990-12-06 1991-06-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-06-06 1994-12-06 1995-06-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag